Download PDF
Semin Thromb Hemost 2011; 37(7): 763-761
DOI: 10.1055/s-0031-1297167
© Thieme Medical Publishers

Thrombosis in Children

Christine A. Macartney1 , Anthony K.C. Chan2
  • 1Department of Paediatric Haematology, Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland, United Kingdom
  • 2Thrombosis & Atherosclerosis Research Institute (TaARI) and Department of Paediatrics, McMaster University, Hamilton, Ontario, Canada
Further Information

Publication History

Publication Date:
20 December 2011 (online)

    Permissions and Reprints

ABSTRACT

Thrombosis in children is becoming more prevalent due to increased awareness of these issues in the pediatric population and advances in medicine. Management of affected children are challenging due to differences in their hemostatic system compared with adults. Prospective, controlled trials for management/treatment of children with thrombosis are lacking. Many of the available guidelines for treatment of thrombosis in children are extrapolated from adult data and do not account for the uniqueness of the pediatric hemostatic system, although more research and data are becoming available. This review will focus on children over 1 year of age, including adolescents, looking at the etiology of thrombosis, diagnosis, management options, and any associated complications in this pediatric population.

KEYWORDS

Thrombosis - pediatrics - anticoagulation

REFERENCES

  • 1 Andrew M, David M, Adams M et al.. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE.  Blood. 1994;  83 (5) 1251-1257
    Google Scholar
  • 2 Male C, Chait P, Ginsberg J S et al.. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase.  Thromb Haemost. 2002;  87 (4) 593-598
    Google Scholar
  • 3 Fraser D G, Moody A R, Davidson I R, Martel A L, Morgan P S. Deep venous thrombosis: diagnosis by using venous enhanced subtracted peak arterial MR venography versus conventional venography.  Radiology. 2003;  226 (3) 812-820
    Google Scholar
  • 4 Shankar K R, Abernethy L J, Das K S et al.. Magnetic resonance venography in assessing venous patency after multiple venous catheters.  J Pediatr Surg. 2002;  37 (2) 175-179
    Google Scholar
  • 5 Biss T T, Brandão L R, Kahr W H, Chan A K, Williams S. Clinical features and outcome of pulmonary embolism in children.  Br J Haematol. 2008;  142 (5) 808-818
    Google Scholar
  • 6 Massicotte M P, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications.  J Pediatr. 1998;  133 (6) 770-776
    Google Scholar
  • 7 Kuhle S, Massicotte P, Chan A et al.. Systemic thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation Service.  Thromb Haemost. 2004;  92 (4) 722-728
    Google Scholar
  • 8 Male C, Foulon D, Hoogendoorn H et al.. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus.  Blood. 2005;  106 (13) 4152-4158
    Google Scholar
  • 9 Newall F, Barnes C, Ignjatovic V, Monagle P. Heparin-induced thrombocytopenia in children.  J Paediatr Child Health. 2003;  39 (4) 289-292
    Google Scholar
  • 10 Saxon B R, Black M D, Edgell D, Noel D, Leaker M T. Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran).  Ann Thorac Surg. 1999;  68 (3) 1076-1078
    Google Scholar
  • 11 Chan V H, Monagle P, Massicotte P, Chan A K. Novel paediatric anticoagulants: a review of the current literature.  Blood Coagul Fibrinolysis. 2010;  21 (2) 144-151
    Google Scholar
  • 12 van Ommen C H, Heijboer H, van den Dool E J, Hutten B A, Peters M. Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome.  J Thromb Haemost. 2003;  1 (12) 2516-2522
    Google Scholar
  • 13 Young G, Albisetti M, Bonduel M et al.. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies.  Circulation. 2008;  118 (13) 1373-1382
    Google Scholar
  • 14 Revel-Vilk S, Chan A, Bauman M, Massicotte P. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease.  J Thromb Haemost. 2003;  1 (5) 915-921
    Google Scholar
  • 15 Schneppenheim R, Greiner J. Thrombosis in infants and children.  Hematology (Am Soc Hematol Educ Program). 2006;  (1) 86-96
    Google Scholar
  • 16 Nowak-Göttl U, Sträter R, Heinecke A et al.. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood.  Blood. 1999;  94 (11) 3678-3682
    Google Scholar
  • 17 Aschka I, Aumann V, Bergmann F et al.. Prevalence of factor V Leiden in children with thrombo-embolism.  Eur J Pediatr. 1996;  155 (12) 1009-1014
    Google Scholar
  • 18 Nowak-Göttl U, Junker R, Hartmeier M et al.. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood.  Circulation. 1999;  100 (7) 743-748
    Google Scholar
  • 19 Raffini L, Raybagkar D, Cahill A M, Kaye R, Blumenstein M, Manno C. May-Thurner syndrome (iliac vein compression) and thrombosis in adolescents.  Pediatr Blood Cancer. 2006;  47 (6) 834-838
    Google Scholar
  • 20 Monagle P, Chalmers E, Chan A American College of Chest Physicians et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).  Chest. 2008;  133 (6, Suppl) 887S-968S
    Google Scholar
  • 21 Streif W, Andrew M, Marzinotto V et al.. Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients.  Blood. 1999;  94 (9) 3007-3014
    Google Scholar
  • 22 Hirsh J. Heparin.  N Engl J Med. 1991;  324 (22) 1565-1574
    Google Scholar
  • 23 Newall F, Ignjatovic V, Johnston L et al.. Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin.  Thromb Haemost. 2010;  103 (5) 1085-1090
    Google Scholar
  • 24 Chan A K, Black L, Ing C, Brandão L R, Williams S. Utility of aPTT in monitoring unfractionated heparin in children.  Thromb Res. 2008;  122 (1) 135-136
    Google Scholar
  • 25 Raschke R A, Reilly B M, Guidry J R, Fontana J R, Srinivas S. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. A randomized controlled trial.  Ann Intern Med. 1993;  119 (9) 874-881
    Google Scholar
  • 26 Avioli L V. Heparin-induced osteopenia: an appraisal.  Adv Exp Med Biol. 1975;  52 375-387
    Google Scholar
  • 27 Kuhle S, Eulmesekian P, Kavanagh B, Massicotte P, Vegh P, Mitchell L G. A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: a prospective cohort study.  Haematologica. 2007;  92 (2) 244-247
    Google Scholar
  • 28 Schmugge M, Risch L, Huber A R, Benn A, Fischer J E. Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients.  Pediatrics. 2002;  109 (1) E10
    Google Scholar
  • 29 Crowther M A, Berry L R, Monagle P T, Chan A K. Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin.  Br J Haematol. 2002;  116 (1) 178-186
    Google Scholar
  • 30 Malowany J I, Monagle P, Knoppert D C Canadian Paediatric Thrombosis and Hemostasis Network et al. Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates.  Thromb Res. 2008;  122 (6) 826-830
    Google Scholar
  • 31 O'Brien S H, Lee H, Ritchey A K. Once-daily enoxaparin in pediatric thromboembolism: a dose finding and pharmacodynamics/pharmacokinetics study.  J Thromb Haemost. 2007;  5 (9) 1985-1987
    Google Scholar
  • 32 Baglin T, Barrowcliffe T W, Cohen A, Greaves M. British Committee for Standards in Haematology . Guidelines on the use and monitoring of heparin.  Br J Haematol. 2006;  133 (1) 19-34
    Google Scholar
  • 33 Kuhle S, Massicotte P, Dinyari M et al.. Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events.  Thromb Haemost. 2005;  94 (6) 1164-1171
    Google Scholar
  • 34 Massicotte P, Adams M, Marzinotto V, Brooker L A, Andrew M. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study.  J Pediatr. 1996;  128 (3) 313-318
    Google Scholar
  • 35 Garcia D, Libby E, Crowther M A. The new oral anticoagulants.  Blood. 2010;  115 (1) 15-20
    Google Scholar
  • 36 Goldenberg N A, Durham J D, Knapp-Clevenger R, Manco-Johnson M J. A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children.  Blood. 2007;  110 (1) 45-53
    Google Scholar
  • 37 Yee D L, Chan A K, Williams S, Goldenberg N A, Massicotte M P, Raffini L J. Varied opinions on thrombolysis for venous thromboembolism in infants and children: findings from a survey of pediatric hematology-oncology specialists.  Pediatr Blood Cancer. 2009;  53 (6) 960-966
    Google Scholar
  • 38 Raffini L, Cahill A M, Hellinger J, Manno C. A prospective observational study of IVC filters in pediatric patients.  Pediatr Blood Cancer. 2008;  51 (4) 517-520
    Google Scholar
  • 39 Cook A, Shackford S, Osler T, Rogers F, Sartorelli K, Littenberg B. Use of vena cava filters in pediatric trauma patients: data from the National Trauma Data Bank.  J Trauma. 2005;  59 (5) 1114-1120
    Google Scholar
  • 40 Greenfield L J, Proctor M C. Thromboembolism: prevention and treatment with vena cava filters.  Semin Arthroplasty. 1992;  3 (2) 123-127
    Google Scholar
  • 41 Poon W L, Luk S H, Yam K Y, Lee A C. Mechanical thrombectomy in inferior vena cava thrombosis after caval filter placement: a report of three cases.  Cardiovasc Intervent Radiol. 2002;  25 (5) 440-443
    Google Scholar
  • 42 Bogue C O, John P R, Connolly B L, Rea D J, Amaral J G. Symptomatic caval penetration by a Celect inferior vena cava filter.  Pediatr Radiol. 2009;  39 (10) 1110-1113
    Google Scholar
  • 43 Cahn M D, Rohrer M J, Martella M B, Cutler B S. Long-term follow-up of Greenfield inferior vena cava filter placement in children.  J Vasc Surg. 2001;  34 (5) 820-825
    Google Scholar
  • 44 Prandoni P, Villalta S, Polistena P, Bernardi E, Cogo A, Girolami A. Symptomatic deep-vein thrombosis and the post-thrombotic syndrome.  Haematologica. 1995;  80 (2, Suppl) 42-48
    Google Scholar
  • 45 Goldenberg N A, Donadini M P, Kahn S R et al.. Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors.  Haematologica. 2010;  95 (11) 1952-1959
    Google Scholar
  • 46 Monagle P, Adams M, Mahoney M et al.. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry.  Pediatr Res. 2000;  47 (6) 763-766
    Google Scholar
  • 47 Kuhle S, Koloshuk B, Marzinotto V et al.. A cross-sectional study evaluating post-thrombotic syndrome in children.  Thromb Res. 2003;  111 (4-5) 227-233
    Google Scholar
  • 48 van Ommen C H, Ottenkamp J, Lam J et al.. The risk of postthrombotic syndrome in children with congenital heart disease.  J Pediatr. 2002;  141 (4) 582-586
    Google Scholar
  • 49 Goldenberg N A, Knapp-Clevenger R, Manco-Johnson M J. Mountain States Regional Thrombophilia Group . Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children.  N Engl J Med. 2004;  351 (11) 1081-1088
    Google Scholar
  • 50 Baglin T. Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: not yet.  J Thromb Haemost. 2006;  4 (12) 2530-2532
    Google Scholar

Christine A. MacartneyM.B. D.C.H. M.R.C.P. F.R.C.Path. 

Department of Paediatric Haematology, Royal Belfast Hospital for Sick Children, Falls Road

Belfast BT12 6BE, Northern Ireland, United Kingdom

Email: christine.macartney@belfasttrust.hscni.net

      >